Post-translational
modifications (PTMs) are one of the most important
regulatory mechanisms in cells, and they play key roles in cell signaling
both in health and disease. PTM catalyzing enzymes have become significant
drug targets, and therefore, tremendous interest has been focused
on the development of broad-scale assays to monitor several different
PTMs with a single detection platform. Most of the current methodologies
suffer from low throughput or rely on antibody recognition, increasing
the assay costs, and decreasing the multifunctionality of the assay.
Thus, we have developed a sensitive time-resolved Förster resonance
energy transfer (TR-FRET) detection method for PTMs of cysteine residues
using a single-peptide approach performed in a 384-well format. In
the developed assay, the enzyme-specific biotinylated substrate peptide
is post-translationally modified at the cysteine residue, preventing
the subsequent thiol coupling with a reactive AlexaFluor 680 acceptor
dye. In the absence of enzymatic activity, increase in the TR-FRET
signal between the biotin-bound Eu(III)-labeled streptavidin donor
and the cysteine-coupled AlexaFluor 680 acceptor dye is observed.
We demonstrate the detection concept with cysteine modifying S-nitrosylation
and ADP-ribosylation reactions using a chemical nitric oxide donor
S-nitrosoglutathione and enzymatic ADP-ribosyltransferase PtxS1-subunit
of pertussis toxin, respectively. As a proof of concept, three peptide
substrates derived from the small GTPase K-Ras and the inhibitory
α-subunit of the heterotrimeric G-protein Gαi showed expected
functionality in both chemical and enzymatic assays. Measurements
yielded signal-to-background ratios of 28.7, 33.0, and 8.7 between
the modified and the nonmodified substrates for the three peptides
in the S-nitrosylation assay, 5.8 in the NAD
+
hydrolysis
assay, and 6.8 in the enzymatic ADP-ribosyltransferase inhibitor dose–response
assay. The developed antibody-free assay for cysteine-modifying enzymes
provides a detection platform with low nanomolar peptide substrate
consumption, and the assay is potentially applicable to investigate
various cysteine-modifying enzymes in a high throughput compatible
format.